High Way To Market: helping clients expedite drug development timelines.
Eurofins CDMO (Contract Development & Manufacturing Organization) provides integrated, end to end solutions for preclinical & clinical outsourcing services of both Drug Substance/API and Drug Product for NBEs and NCEs. Learn More.
Eurofins CDMO (Contract Development & Manufacturing Organization) helps pharmaceutical and biopharmaceutical companies move rapidly from research stage of NCE/NBE development to clinical stages with integrated and time-efficient services to help compress timelines to market.
From formulation screening and development, analytical development, stability studies and pre-clinical safety assessment studies to sterile and non-sterile manufacturing, IND/ IMPD and NDA/ CTD services, as well as clinical trial material including packaging and logistics, Eurofins CDMO delivers comprehensive solutions to streamline the development and manufacturing of a variety of product types, delivery systems and dosage forms.
With 13 state-of-the-art facilities in the US, Europe and India and global regulatory expertise, Eurofins CDMO provides high-quality, customized solutions for complex products and unique production processes, specializing in the development of innovative formulation technologies and solutions to enhance bioavailability and control drug release for difficult-to-formulate drug candidates.
Choose Eurofins CDMO to help you:
✔ Consolidate vendors to move rapidly through the drug development value chain
✔ Navigate complex formulation screening and development
✔ Accelerate process development and scale-up
✔ Oversee the life-cycle management of existing drugs
✔ Ensure regulatory compliance throughout each stage of the development cycle